ImpediMed Limited IPD.AX Stock
ImpediMed Limited Price Chart
ImpediMed Limited IPD.AX Financial and Trading Overview
| ImpediMed Limited stock price | 0.09 AUD |
| Previous Close | 0.15 AUD |
| Open | 0.16 AUD |
| Bid | 0.15 AUD x 0 |
| Ask | 0.16 AUD x 0 |
| Day's Range | 0.15 - 0.16 AUD |
| 52 Week Range | 0.05 - 0.19 AUD |
| Volume | 1.69M AUD |
| Avg. Volume | 6.2M AUD |
| Market Cap | 300.86M AUD |
| Beta (5Y Monthly) | 2.949808 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.17 AUD |
IPD.AX Valuation Measures
| Enterprise Value | 251.57M AUD |
| Trailing P/E | N/A |
| Forward P/E | -15.5 |
| PEG Ratio (5 yr expected) | -200 |
| Price/Sales (ttm) | 27.289 |
| Price/Book (mrq) | 6.7391305 |
| Enterprise Value/Revenue | 22.818 |
| Enterprise Value/EBITDA | -11.09 |
Trading Information
ImpediMed Limited Stock Price History
| Beta (5Y Monthly) | 2.949808 |
| 52-Week Change | 120.58% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.19 AUD |
| 52 Week Low | 0.05 AUD |
| 50-Day Moving Average | 0.15 AUD |
| 200-Day Moving Average | 0.09 AUD |
IPD.AX Share Statistics
| Avg. Volume (3 month) | 6.2M AUD |
| Avg. Daily Volume (10-Days) | 4.59M AUD |
| Shares Outstanding | 1.94B |
| Float | 1.59B |
| Short Ratio | N/A |
| % Held by Insiders | 13.89% |
| % Held by Institutions | 14.95% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -197.45% |
| Operating Margin (ttm) | -214.75% |
| Gross Margin | 87.00% |
| EBITDA Margin | -205.75% |
Management Effectiveness
| Return on Assets (ttm) | -25.57% |
| Return on Equity (ttm) | -43.69% |
Income Statement
| Revenue (ttm) | 11.03M AUD |
| Revenue Per Share (ttm) | 0.006 AUD |
| Quarterly Revenue Growth (yoy) | 8.79% |
| Gross Profit (ttm) | 9.16M AUD |
| EBITDA | -22685000 AUD |
| Net Income Avi to Common (ttm) | -21696000 AUD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 26.2M AUD |
| Total Cash Per Share (mrq) | 0.02 AUD |
| Total Debt (mrq) | 1.33M AUD |
| Total Debt/Equity (mrq) | 3.26 AUD |
| Current Ratio (mrq) | 5.469 |
| Book Value Per Share (mrq) | 0.023 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -21575000 AUD |
| Levered Free Cash Flow (ttm) | -18146124 AUD |
Profile of ImpediMed Limited
| Country | Australia |
| State | QLD |
| City | Pinkenba |
| Address | 50 Parker Court |
| ZIP | 4008 |
| Phone | 61 7 3860 3700 |
| Website | https://www.impedimed.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 73 |
ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.
Q&A For ImpediMed Limited Stock
What is a current IPD.AX stock price?
ImpediMed Limited IPD.AX stock price today per share is 0.09 AUD.
How to purchase ImpediMed Limited stock?
You can buy IPD.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ImpediMed Limited?
The stock symbol or ticker of ImpediMed Limited is IPD.AX.
Which industry does the ImpediMed Limited company belong to?
The ImpediMed Limited industry is Medical Devices.
How many shares does ImpediMed Limited have in circulation?
The max supply of ImpediMed Limited shares is 2.02B.
What is ImpediMed Limited Price to Earnings Ratio (PE Ratio)?
ImpediMed Limited PE Ratio is now.
What was ImpediMed Limited earnings per share over the trailing 12 months (TTM)?
ImpediMed Limited EPS is -0.01 AUD over the trailing 12 months.
Which sector does the ImpediMed Limited company belong to?
The ImpediMed Limited sector is Healthcare.